InvestorsHub Logo
Followers 53
Posts 6518
Boards Moderated 0
Alias Born 02/13/2012

Re: exwannabe post# 261361

Saturday, 01/25/2020 12:58:38 PM

Saturday, January 25, 2020 12:58:38 PM

Post# of 701404
Not surprised to see someone can say something negative about this UCLA trial. Anyway you slice it, DCVAX is licensed to NWBO for commercial use. If the trial is a success the winner is NWBO. If the control arm is superior it says DCVAX is still a big win because DCVAX by itself is the control. Two ways of winning. Another way of winning is not having to pay for the trial.

Just good news period!

The other Merck DCVAX trial was supposed to be in Mainz Germany. Colorectal Cancer. It would be nice to know what has happened with that one. Also a trial NWBO will not be saddled with a large financial burden.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News